haloperidol has been researched along with Bone Loss, Osteoclastic in 5 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with haloperidol did not affect bone density." | 1.37 | The atypical anti-psychotic clozapine decreases bone mass in rats in vivo. ( Callon, K; Cheng, A; Cornish, J; Costa, JL; Gamble, G; Grey, A; Lin, JM; Shepherd, PR; Smith, G; Vickers, MH; Watson, M, 2011) |
| "This bone resorption depended on the surface energy and roughness of the foreign surface, varying with these physical properties rather than with the chemical nature of the material." | 1.28 | The influence of the surface energy and roughness of implants on bone resorption. ( Murray, DW; Rae, T; Rushton, N, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, Y | 1 |
| Su, YA | 1 |
| Zhao, ZG | 1 |
| Gao, N | 1 |
| Huang, JZ | 1 |
| Tang, MQ | 1 |
| Li, KQ | 1 |
| Yang, FD | 1 |
| Yu, X | 1 |
| Si, TM | 1 |
| Costa, JL | 1 |
| Smith, G | 1 |
| Watson, M | 1 |
| Lin, JM | 1 |
| Callon, K | 1 |
| Gamble, G | 1 |
| Cheng, A | 1 |
| Vickers, MH | 1 |
| Shepherd, PR | 1 |
| Cornish, J | 1 |
| Grey, A | 1 |
| Kim, TG | 1 |
| Lee, YH | 1 |
| Lee, NH | 1 |
| Bhattarai, G | 1 |
| Lee, IK | 1 |
| Yun, BS | 1 |
| Yi, HK | 1 |
| Coon, D | 1 |
| Gulati, A | 1 |
| Cowan, C | 1 |
| He, J | 1 |
| Murray, DW | 1 |
| Rae, T | 1 |
| Rushton, N | 1 |
1 trial available for haloperidol and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Biomarkers; Bone Remodeling; Bone Resorption; Female; Halo | 2015 |
4 other studies available for haloperidol and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
The atypical anti-psychotic clozapine decreases bone mass in rats in vivo.
Topics: Absorptiometry, Photon; Analysis of Variance; Animals; Antipsychotic Agents; Bone and Bones; Bone De | 2011 |
The antioxidant property of pachymic acid improves bone disturbance against AH plus-induced inflammation in MC-3T3 E1 cells.
Topics: 3T3 Cells; Animals; Anti-Inflammatory Agents; Antioxidants; Bone Resorption; Cell Survival; Epoxy Re | 2013 |
The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption.
Topics: Acid Phosphatase; Aluminum Compounds; Animals; Biomarkers; Bone Resorption; Calcium Compounds; Cells | 2007 |
The influence of the surface energy and roughness of implants on bone resorption.
Topics: Animals; Bone Resorption; Cell Adhesion; Cells, Cultured; Dinoprostone; Epoxy Resins; Foreign-Body R | 1989 |